Viewing Study NCT02065466


Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-02-22 @ 9:38 AM
Study NCT ID: NCT02065466
Status: WITHDRAWN
Last Update Posted: 2016-04-21
First Post: 2014-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
Sponsor: University of Arizona
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Melanoma View
None Brain Metastases View
Keywords: